Light Mode
$12.35 ↑ +0.00 (+0.00%) Trading Up from the previous close of $12.35, $0.68 below the day’s high of $13.03
-3.65 (-22.81%) / 6M
Momentum, market sentiment, and recent alerts
BLSM reads poor: the 12-month move is -22.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Blossomhill Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded on June 22, 2020 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.